Heublein, Sabine
Anglesio, Michael S.
Marmé, Frederik http://orcid.org/0000-0002-6591-3367
Kommoss, Stefan
Article History
Received: 1 July 2019
Accepted: 23 July 2019
First Online: 5 August 2019
Compliance with ethical standards
:
: Sabine Heublein received research support from Novartis, Ferring, Apceth and Addex; Honoria from Roche, travel expenses from Astra Zeneca. Frederik Marmé received honoraria from Roche, AstraZeneca, Pfizer, Clovis, Tesaro, Amgen, Celgene, Eisai, MSD, Genomic Health, Curevac; Travel expenses from Roche, Pfizer, Astra Zeneca, Pharma-Mar, Amgen, Celgene; Advisory Boards for Roche, Astra Zeneca, Pfizer, MSD, Amgen, Celgene, Genomic Health, Curevac. Stefan Kommoss and Michael S. Anglesio declare no competing interests.
: Collection of patient specimens and data from the British Columbia cohort was done under approved research protocols reviewed by the British Columbia Cancer Agency and University of British Columbia research ethics board (H05-60119).
: No written informed consent of the participants is needed given the circumstances described above.